EUVIMEDEUVIMED entdecken
Open Access

Dual Potential of Cetuximab Conjugated Hydroxyapatite Zirconium Nanoparticle as Nanocarrier for Radioenhancer in X-Ray Dynamic Therapy and 177 Lu-based Radioimmunotherapy of Lung Cancer

Ahmad Kurniawan, Isa Mahendra, Asep Rizaludin, Marhendra Satria Utama, Ronny Lesmana, Fitria Dwi Ayuningtyas, Maria Rosa Dewanti, Dani Gustaman Syarif, Muhamad Basit Febrian

Nanotheranostics · 2025

DOI: 10.7150/ntno.101699 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanotheranostics, 2025. Verfasst von Ahmad Kurniawan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Radioisotope, Radiopharmaceuticals and Biodosimetry Technology, National Research and Innovation Agency, Serpong, Indonesia. Hauptthemen laut MEDLINE: Zirconium, Lung Neoplasms, Lutetium, Radioisotopes. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZirconiumLung NeoplasmsLutetiumRadioisotopesDurapatiteCetuximabRadioimmunotherapyNanoparticlesDrug CarriersHumansAnimalsMiceA549 CellsX-RaysMice, Inbred BALB C

Stichwörter der Autor:innen

CetuximabHydroxyapatiteLung cancerNanoparticleRadioimmunotherapyX-ray dynamic therapy

Substanzen

ZirconiumLutetiumRadioisotopesDurapatiteCetuximabLutetium-177Drug Carriers

Autor:innen und Institutionen

  • Research Center for Radioisotope, Radiopharmaceuticals and Biodosimetry Technology, National Research and Innovation Agency, Serpong, Indonesia.
  • Department of Radiology, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, Bandung, Indonesia.
  • Department of Biomedical Science, Physiology Division, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
  • ITB Olympus Bioimaging Center, Bandung Institute of Technology, Bandung, Indonesia.
  • Indonesian Polytechnic of Nuclear Technology, Sleman, Indonesia.
  • Research Center for Radiation Process Technology, National Research and Innovation Agency, Serpong, Indonesia.

Zitieren

APA

Kurniawan, A., Mahendra, I., Rizaludin, A., Utama, M. S., Lesmana, R., Ayuningtyas, F. D., Dewanti, M. R., Syarif, D. G., & Febrian, M. B. (2025). Dual Potential of Cetuximab Conjugated Hydroxyapatite Zirconium Nanoparticle as Nanocarrier for Radioenhancer in X-Ray Dynamic Therapy and 177 Lu-based Radioimmunotherapy of Lung Cancer. Nanotheranostics. https://doi.org/10.7150/ntno.101699

Vancouver

Kurniawan A, Mahendra I, Rizaludin A, Utama MS, Lesmana R, Ayuningtyas FD, et al. Dual Potential of Cetuximab Conjugated Hydroxyapatite Zirconium Nanoparticle as Nanocarrier for Radioenhancer in X-Ray Dynamic Therapy and 177 Lu-based Radioimmunotherapy of Lung Cancer. Nanotheranostics. 2025. doi:10.7150/ntno.101699

BibTeX
@article{Kurniawan2025,
  author = {Kurniawan, Ahmad and Mahendra, Isa and Rizaludin, Asep and Utama, Marhendra Satria and Lesmana, Ronny and Ayuningtyas, Fitria Dwi and Dewanti, Maria Rosa and Syarif, Dani Gustaman and Febrian, Muhamad Basit},
  title = {Dual Potential of Cetuximab Conjugated Hydroxyapatite Zirconium Nanoparticle as Nanocarrier for Radioenhancer in X-Ray Dynamic Therapy and 177 Lu-based Radioimmunotherapy of Lung Cancer},
  journal = {Nanotheranostics},
  year = {2025},
  doi = {10.7150/ntno.101699}
}
Kostenlos starten →